Meeting
2020 Genitourinary Cancers Symposium
Clinical utility of PSA density and PI-RADS for deferring biopsy for the detection of clinically significant prostate cancer.
Authors
Matthew Truong
Cleveland Clinic, Cleveland, OH
Matthew Truong , Erica Stevens , Ryan Ward , Jennifer Bullen , Ethan Austhof , Rogelio Valdez , Andrei Purysko , Eric A. Klein
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Prostate Cancer
Track
Prostate Cancer - Advanced,Prostate Cancer - Localized
Sub Track
Imaging
Citation
J Clin Oncol 38, 2020 (suppl 6; abstr 298)
Abstract #
298
Poster Bd #
L4
Abstract Disclosures
Similar Posters
Poster
2020 Genitourinary Cancers Symposium
Clinical utility of biomarkers 4K score, SelectMDx and ExoDx with MRI for the detection of high-grade prostate cancer.
First Author: Vittorio Fasulo
Poster
2019 Genitourinary Cancers Symposium
Increasing utilization of multi-parametric magnetic resonance imaging in prostate cancer active surveillance.
First Author: Avinash Maganty
Poster
2018 Genitourinary Cancers Symposium
Outcomes of serial MRI/ultrasound fusion targeted biopsy in men with very low-risk and low-risk prostate cancer managed with active surveillance.
First Author: Walter Hsiang
Poster
2024 ASCO Genitourinary Cancers Symposium
The Capio Prostate Cancer Center model for prostate cancer diagnostics using Stockholm3, MRI, and targeted biopsies: Real-world evidence from 2018 to 2022.
First Author: Thorgerdur Palsdottir